Pregnancy or suspected pregnancy (that cannot yet be excluded) or breast feeding.
Moderate to severe hypertension.
Arterial thrombosis present or in history (e.g. myocardial infarction, cerebrovascular accident).
In addition the presence of more than one of the risk factors for arterial disease.
History of confirmed venous thromboembolism (VTE); Family history of idiopathic VTE. Other known risk factors for VTE.
Diabetes mellitus with vascular involvement.
Severe liver disease, cholestatic jaundice or hepatitis (viral or non-viral), or a history of these conditions if the results of liver function tests have failed to return to normal, and for 3 months after liver function tests have been found to be normal; a history of jaundice of pregnancy or jaundice due to the use of steroids, Rotor syndrome and Dubin-Johnson syndrome, hepatic cell tumours and porphyria.
Known or suspected estrogen-dependent tumours, endometrial hyperplasia; undiagnosed vaginal bleeding.
Systemic lupus erythematosus or a history of this condition.
A history during pregnancy or previous use of steroids of: Severe pruritis; pemphigoid gestationis; jaundice; a manifestation or deterioration of otosclerosis.
Hypersensitivity to any of the components of Daisy-30.